If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
Gene and significance breakdown #
Total genes and gene combinations: 398
| Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
|
APC
|
1270
|
82
|
146
|
287
|
1859
|
3644
|
|
ATM
|
791
|
188
|
2
|
563
|
1215
|
2759
|
|
MSH6
|
934
|
111
|
93
|
304
|
1305
|
2747
|
|
TSC2
|
12
|
9
|
0 |
725
|
1475
|
2221
|
|
MSH2
|
720
|
189
|
55
|
391
|
788
|
2143
|
|
PALB2
|
712
|
81
|
57
|
274
|
788
|
1912
|
|
MLH1
|
639
|
154
|
27
|
315
|
599
|
1734
|
|
ATM, C11orf65
|
448
|
164
|
2
|
366
|
643
|
1622
|
|
BRIP1
|
422
|
79
|
100
|
231
|
714
|
1546
|
|
PMS2
|
333
|
113
|
69
|
232
|
757
|
1504
|
|
CDH1
|
222
|
78
|
85
|
279
|
674
|
1338
|
|
BARD1
|
303
|
63
|
16
|
199
|
594
|
1175
|
|
CHEK2
|
326
|
139
|
65
|
220
|
341
|
1091
|
|
TP53
|
165
|
259
|
39
|
131
|
293
|
887
|
|
AXIN2
|
47
|
5
|
0 |
145
|
652
|
849
|
|
PTEN
|
309
|
119
|
12
|
120
|
262
|
822
|
|
TSC1
|
22
|
9
|
0 |
242
|
516
|
789
|
|
SDHA
|
79
|
47
|
30
|
156
|
397
|
709
|
|
MET
|
0 |
1
|
0 |
172
|
529
|
702
|
|
STK11
|
33
|
12
|
40
|
140
|
437
|
662
|
|
CTNNA1
|
65
|
12
|
0 |
147
|
391
|
615
|
|
BAP1
|
59
|
15
|
0 |
181
|
348
|
603
|
|
RAD51C
|
92
|
96
|
12
|
123
|
257
|
580
|
|
SMAD4
|
41
|
13
|
15
|
127
|
373
|
569
|
|
BMPR1A
|
57
|
14
|
17
|
139
|
337
|
564
|
|
FLCN
|
66
|
17
|
0 |
172
|
300
|
555
|
|
RAD51D, RAD51L3-RFFL
|
79
|
52
|
12
|
145
|
259
|
547
|
|
BRCA2
|
308
|
20
|
0 |
114
|
25
|
467
|
|
MEN1
|
26
|
10
|
2
|
87
|
305
|
430
|
|
FH
|
49
|
45
|
1
|
84
|
222
|
401
|
|
RET
|
24
|
6
|
20
|
114
|
226
|
390
|
|
POLD1
|
0 |
3
|
6
|
124
|
237
|
370
|
|
CDKN2A
|
32
|
30
|
16
|
27
|
222
|
327
|
|
MSH3
|
233
|
58
|
0 |
2
|
0 |
293
|
|
POLE
|
0 |
0 |
13
|
95
|
161
|
269
|
|
BRCA1
|
116
|
25
|
4
|
96
|
22
|
263
|
|
HOXB13
|
0 |
0 |
0 |
17
|
231
|
248
|
|
SDHB
|
40
|
21
|
5
|
53
|
115
|
234
|
|
DNAH5
|
4
|
191
|
0 |
0 |
0 |
195
|
|
CDK4
|
0 |
0 |
2
|
45
|
127
|
174
|
|
NEB
|
6
|
167
|
0 |
0 |
0 |
173
|
|
SDHC
|
21
|
10
|
4
|
45
|
91
|
171
|
|
LAMA2
|
6
|
161
|
3
|
0 |
0 |
170
|
|
EGFR
|
0 |
1
|
0 |
47
|
102
|
150
|
|
VHL
|
11
|
7
|
0 |
34
|
98
|
150
|
|
PKHD1
|
8
|
116
|
2
|
0 |
0 |
126
|
|
CFTR
|
59
|
66
|
0 |
0 |
0 |
125
|
|
LOC107303340, VHL
|
11
|
5
|
1
|
29
|
75
|
121
|
|
USH2A
|
26
|
75
|
13
|
0 |
0 |
114
|
|
CDK4, TSPAN31
|
0 |
0 |
3
|
26
|
81
|
110
|
|
MYO7A
|
6
|
95
|
6
|
0 |
0 |
107
|
|
SDHD
|
9
|
2
|
0 |
27
|
66
|
104
|
|
DYSF
|
7
|
91
|
3
|
0 |
0 |
101
|
|
ZFYVE26
|
1
|
99
|
1
|
0 |
0 |
101
|
|
COL4A3, MFF-DT
|
2
|
85
|
2
|
0 |
0 |
89
|
|
COL4A4
|
3
|
84
|
1
|
0 |
0 |
88
|
|
NTHL1
|
73
|
14
|
0 |
1
|
0 |
88
|
|
AGL
|
2
|
74
|
0 |
0 |
0 |
76
|
|
COL4A5
|
2
|
73
|
0 |
0 |
0 |
75
|
|
ATP7B
|
11
|
56
|
6
|
0 |
0 |
73
|
|
CPS1
|
1
|
68
|
1
|
0 |
0 |
70
|
|
GNPTAB
|
3
|
66
|
0 |
0 |
0 |
69
|
|
NPC1
|
4
|
62
|
2
|
0 |
0 |
68
|
|
DMD
|
7
|
60
|
0 |
0 |
0 |
67
|
|
GLDC
|
1
|
61
|
3
|
0 |
0 |
65
|
|
ATP7A
|
0 |
61
|
0 |
0 |
0 |
61
|
|
LAMB3
|
5
|
54
|
0 |
0 |
0 |
59
|
|
LRPPRC
|
0 |
58
|
0 |
0 |
0 |
58
|
|
LOC130062899, STK11
|
3
|
0 |
3
|
7
|
44
|
57
|
|
ALMS1
|
0 |
56
|
0 |
0 |
0 |
56
|
|
ERCC6
|
2
|
53
|
0 |
0 |
0 |
55
|
|
PCDH15
|
4
|
44
|
5
|
0 |
0 |
53
|
|
ELP1
|
3
|
48
|
0 |
0 |
0 |
51
|
|
MAN2B1
|
3
|
48
|
0 |
0 |
0 |
51
|
|
MTTP
|
1
|
50
|
0 |
0 |
0 |
51
|
|
PAH
|
23
|
28
|
0 |
0 |
0 |
51
|
|
SLC26A4
|
14
|
27
|
9
|
0 |
0 |
50
|
|
ABCC8
|
4
|
37
|
6
|
0 |
0 |
47
|
|
FANCA
|
8
|
39
|
0 |
0 |
0 |
47
|
|
GAA
|
13
|
30
|
3
|
0 |
0 |
46
|
|
BLM
|
33
|
7
|
0 |
2
|
3
|
45
|
|
EVC
|
1
|
43
|
0 |
0 |
0 |
44
|
|
HEXA
|
9
|
34
|
1
|
0 |
0 |
44
|
|
SACS
|
19
|
25
|
0 |
0 |
0 |
44
|
|
VPS13B
|
11
|
31
|
1
|
0 |
0 |
43
|
|
EVC2
|
3
|
38
|
1
|
0 |
0 |
42
|
|
LAMC2
|
1
|
41
|
0 |
0 |
0 |
42
|
|
LOC129390903, RAD51C
|
14
|
7
|
0 |
6
|
15
|
42
|
|
PEX1
|
3
|
37
|
1
|
0 |
0 |
41
|
|
RNF43
|
33
|
6
|
0 |
0 |
2
|
41
|
|
BBS2
|
2
|
36
|
2
|
0 |
0 |
40
|
|
HLCS
|
0 |
39
|
1
|
0 |
0 |
40
|
|
ACADVL
|
7
|
24
|
8
|
0 |
0 |
39
|
|
PC
|
0 |
39
|
0 |
0 |
0 |
39
|
|
NPHS1
|
4
|
30
|
3
|
0 |
0 |
37
|
|
MMUT
|
1
|
34
|
1
|
0 |
0 |
36
|
|
F8
|
16
|
19
|
0 |
0 |
0 |
35
|
|
LOXHD1
|
7
|
27
|
1
|
0 |
0 |
35
|
|
NEB, RIF1
|
0 |
35
|
0 |
0 |
0 |
35
|
|
GALT
|
5
|
28
|
1
|
0 |
0 |
34
|
|
CAPN3
|
9
|
22
|
2
|
0 |
0 |
33
|
|
MUTYH
|
16
|
16
|
0 |
1
|
0 |
33
|
|
BRCA1, LOC126862571
|
16
|
0 |
0 |
14
|
2
|
32
|
|
MPL
|
0 |
32
|
0 |
0 |
0 |
32
|
|
SLC12A6
|
2
|
30
|
0 |
0 |
0 |
32
|
|
HPS3
|
1
|
28
|
0 |
0 |
0 |
29
|
|
CDK4, LOC130008148
|
0 |
0 |
1
|
2
|
25
|
28
|
|
GALC
|
5
|
22
|
1
|
0 |
0 |
28
|
|
GJB2
|
16
|
7
|
5
|
0 |
0 |
28
|
|
HSD17B4
|
0 |
27
|
1
|
0 |
0 |
28
|
|
ASL
|
4
|
22
|
1
|
0 |
0 |
27
|
|
HGSNAT
|
5
|
20
|
2
|
0 |
0 |
27
|
|
IDUA
|
4
|
23
|
0 |
0 |
0 |
27
|
|
PMM2
|
8
|
18
|
1
|
0 |
0 |
27
|
|
TGM1
|
4
|
21
|
2
|
0 |
0 |
27
|
|
CBS
|
4
|
20
|
2
|
0 |
0 |
26
|
|
DHCR7
|
8
|
18
|
0 |
0 |
0 |
26
|
|
GNE
|
7
|
19
|
0 |
0 |
0 |
26
|
|
HEXB
|
1
|
25
|
0 |
0 |
0 |
26
|
|
LOC129933707, MSH6
|
2
|
4
|
1
|
8
|
10
|
25
|
|
PFKM
|
1
|
24
|
0 |
0 |
0 |
25
|
|
MLH3
|
22
|
2
|
0 |
0 |
0 |
24
|
|
PCCA
|
1
|
22
|
1
|
0 |
0 |
24
|
|
ADAMTS2
|
1
|
22
|
0 |
0 |
0 |
23
|
|
DBT
|
1
|
22
|
0 |
0 |
0 |
23
|
|
MTM1
|
0 |
23
|
0 |
0 |
0 |
23
|
|
USH1C
|
3
|
18
|
2
|
0 |
0 |
23
|
|
AGXT
|
3
|
18
|
1
|
0 |
0 |
22
|
|
ARSA
|
7
|
15
|
0 |
0 |
0 |
22
|
|
CYP27A1
|
5
|
17
|
0 |
0 |
0 |
22
|
|
LOC126861339, SDHD
|
5
|
0 |
0 |
3
|
14
|
22
|
|
PEX6
|
2
|
20
|
0 |
0 |
0 |
22
|
|
AIRE
|
5
|
16
|
0 |
0 |
0 |
21
|
|
ALDH3A2
|
2
|
19
|
0 |
0 |
0 |
21
|
|
BCKDHA
|
2
|
18
|
1
|
0 |
0 |
21
|
|
CNGB3
|
1
|
18
|
2
|
0 |
0 |
21
|
|
DLD
|
3
|
18
|
0 |
0 |
0 |
21
|
|
HBB, LOC106099062, LOC107133510
|
16
|
5
|
0 |
0 |
0 |
21
|
|
NBN
|
0 |
21
|
0 |
0 |
0 |
21
|
|
LIPA
|
6
|
14
|
0 |
0 |
0 |
20
|
|
SLC22A5
|
5
|
13
|
2
|
0 |
0 |
20
|
|
BCKDHB
|
2
|
16
|
1
|
0 |
0 |
19
|
|
CPT1A
|
3
|
16
|
0 |
0 |
0 |
19
|
|
F11
|
1
|
16
|
2
|
0 |
0 |
19
|
|
GALK1
|
2
|
16
|
1
|
0 |
0 |
19
|
|
MKS1
|
1
|
18
|
0 |
0 |
0 |
19
|
|
TPP1
|
4
|
15
|
0 |
0 |
0 |
19
|
|
ACADM
|
4
|
14
|
0 |
0 |
0 |
18
|
|
ALPL
|
4
|
13
|
1
|
0 |
0 |
18
|
|
CYP11B1, LOC106799833
|
0 |
17
|
1
|
0 |
0 |
18
|
|
GLB1
|
1
|
17
|
0 |
0 |
0 |
18
|
|
POMGNT1, TSPAN1
|
4
|
14
|
0 |
0 |
0 |
18
|
|
SMPD1
|
5
|
9
|
4
|
0 |
0 |
18
|
|
ALG6
|
0 |
16
|
1
|
0 |
0 |
17
|
|
COL7A1
|
10
|
7
|
0 |
0 |
0 |
17
|
|
TCIRG1
|
4
|
12
|
1
|
0 |
0 |
17
|
|
TH
|
1
|
16
|
0 |
0 |
0 |
17
|
|
ADA
|
2
|
14
|
0 |
0 |
0 |
16
|
|
EYS
|
10
|
6
|
0 |
0 |
0 |
16
|
|
FAH
|
6
|
10
|
0 |
0 |
0 |
16
|
|
IVD
|
3
|
12
|
1
|
0 |
0 |
16
|
|
MLC1
|
1
|
15
|
0 |
0 |
0 |
16
|
|
NF1
|
13
|
3
|
0 |
0 |
0 |
16
|
|
PEX7
|
3
|
13
|
0 |
0 |
0 |
16
|
|
PKD1, TSC2
|
0 |
0 |
0 |
4
|
12
|
16
|
|
STAR
|
1
|
15
|
0 |
0 |
0 |
16
|
|
TYR
|
5
|
11
|
0 |
0 |
0 |
16
|
|
ALDOB
|
3
|
9
|
3
|
0 |
0 |
15
|
|
CEP290
|
15
|
0 |
0 |
0 |
0 |
15
|
|
CTSK
|
1
|
14
|
0 |
0 |
0 |
15
|
|
GCDH
|
6
|
9
|
0 |
0 |
0 |
15
|
|
HADHA
|
0 |
15
|
0 |
0 |
0 |
15
|
|
ASS1
|
2
|
11
|
1
|
0 |
0 |
14
|
|
BTD
|
7
|
6
|
1
|
0 |
0 |
14
|
|
DYNC2H1
|
7
|
7
|
0 |
0 |
0 |
14
|
|
ERCC8
|
1
|
13
|
0 |
0 |
0 |
14
|
|
FKTN
|
1
|
13
|
0 |
0 |
0 |
14
|
|
GATAD1, PEX1
|
0 |
14
|
0 |
0 |
0 |
14
|
|
HMGCL
|
3
|
9
|
2
|
0 |
0 |
14
|
|
BBS1, ZDHHC24
|
1
|
11
|
1
|
0 |
0 |
13
|
|
BCS1L
|
4
|
8
|
1
|
0 |
0 |
13
|
|
GRHPR
|
1
|
12
|
0 |
0 |
0 |
13
|
|
HGD
|
3
|
10
|
0 |
0 |
0 |
13
|
|
NPC2
|
0 |
13
|
0 |
0 |
0 |
13
|
|
NPHS2
|
3
|
9
|
1
|
0 |
0 |
13
|
|
SLC17A5
|
1
|
12
|
0 |
0 |
0 |
13
|
|
CFTR, LOC111674475
|
9
|
3
|
0 |
0 |
0 |
12
|
|
G6PC1
|
7
|
5
|
0 |
0 |
0 |
12
|
|
GAREM2, HADHA
|
2
|
10
|
0 |
0 |
0 |
12
|
|
LOC122152296, USH2A
|
0 |
11
|
1
|
0 |
0 |
12
|
|
MBD4
|
10
|
2
|
0 |
0 |
0 |
12
|
|
MCOLN1
|
1
|
11
|
0 |
0 |
0 |
12
|
|
MMAA
|
1
|
11
|
0 |
0 |
0 |
12
|
|
MMAB
|
9
|
3
|
0 |
0 |
0 |
12
|
|
SGCA
|
3
|
8
|
1
|
0 |
0 |
12
|
|
SGSH
|
2
|
9
|
1
|
0 |
0 |
12
|
|
AOPEP, FANCC
|
1
|
10
|
0 |
0 |
0 |
11
|
|
ARG1, MED23
|
2
|
9
|
0 |
0 |
0 |
11
|
|
DHFR, MSH3
|
9
|
0 |
0 |
0 |
2
|
11
|
|
FANCC
|
2
|
9
|
0 |
0 |
0 |
11
|
|
KIRREL2, NPHS1
|
1
|
8
|
2
|
0 |
0 |
11
|
|
NAGLU
|
2
|
9
|
0 |
0 |
0 |
11
|
|
OTC
|
3
|
8
|
0 |
0 |
0 |
11
|
|
PCCB
|
1
|
10
|
0 |
0 |
0 |
11
|
|
ACADS
|
1
|
9
|
0 |
0 |
0 |
10
|
|
ASPA, SPATA22
|
4
|
6
|
0 |
0 |
0 |
10
|
|
CDK4, MIR6759, TSPAN31
|
0 |
0 |
0 |
10
|
0 |
10
|
|
CFTR, LOC111674472
|
7
|
3
|
0 |
0 |
0 |
10
|
|
CLN3
|
0 |
9
|
1
|
0 |
0 |
10
|
|
CTNS
|
3
|
7
|
0 |
0 |
0 |
10
|
|
LOC129929542, SDHB
|
2
|
0 |
0 |
4
|
4
|
10
|
|
BBS10
|
5
|
1
|
3
|
0 |
0 |
9
|
|
CDKN2A, LOC130001603
|
0 |
0 |
3
|
1
|
5
|
9
|
|
CHM
|
2
|
7
|
0 |
0 |
0 |
9
|
|
LOC130061310, RAD51C
|
0 |
5
|
0 |
4
|
0 |
9
|
|
PPT1
|
4
|
5
|
0 |
0 |
0 |
9
|
|
BBS1
|
0 |
7
|
1
|
0 |
0 |
8
|
|
CPT2
|
5
|
2
|
1
|
0 |
0 |
8
|
|
ERCC2
|
3
|
5
|
0 |
0 |
0 |
8
|
|
ERCC6, PGBD3
|
0 |
8
|
0 |
0 |
0 |
8
|
|
GNPTG
|
0 |
7
|
1
|
0 |
0 |
8
|
|
LOC126807437, MSH3
|
8
|
0 |
0 |
0 |
0 |
8
|
|
LOC126859690, PKHD1
|
1
|
7
|
0 |
0 |
0 |
8
|
|
MMACHC
|
1
|
6
|
1
|
0 |
0 |
8
|
|
PEX10
|
2
|
6
|
0 |
0 |
0 |
8
|
|
POMGNT1
|
0 |
8
|
0 |
0 |
0 |
8
|
|
PRF1
|
4
|
4
|
0 |
0 |
0 |
8
|
|
CLN6
|
1
|
6
|
0 |
0 |
0 |
7
|
|
DNAH5, LOC126807318
|
0 |
7
|
0 |
0 |
0 |
7
|
|
GBA1, LOC106627981
|
4
|
3
|
0 |
0 |
0 |
7
|
|
IDS, LOC106050102
|
0 |
7
|
0 |
0 |
0 |
7
|
|
LAMA3
|
2
|
5
|
0 |
0 |
0 |
7
|
|
NR2E3
|
5
|
2
|
0 |
0 |
0 |
7
|
|
NTRK1
|
6
|
1
|
0 |
0 |
0 |
7
|
|
POLG
|
1
|
6
|
0 |
0 |
0 |
7
|
|
RPE65
|
4
|
3
|
0 |
0 |
0 |
7
|
|
SLC26A2
|
5
|
2
|
0 |
0 |
0 |
7
|
|
SLC37A4
|
5
|
2
|
0 |
0 |
0 |
7
|
|
TAT
|
0 |
7
|
0 |
0 |
0 |
7
|
|
TNXB
|
7
|
0 |
0 |
0 |
0 |
7
|
|
ABCD1
|
1
|
5
|
0 |
0 |
0 |
6
|
|
CDKL5, RS1
|
4
|
2
|
0 |
0 |
0 |
6
|
|
CLRN1
|
5
|
0 |
1
|
0 |
0 |
6
|
|
CP, HPS3
|
0 |
6
|
0 |
0 |
0 |
6
|
|
CYP21A2, LOC106780800
|
6
|
0 |
0 |
0 |
0 |
6
|
|
EVC, LOC129992144
|
0 |
6
|
0 |
0 |
0 |
6
|
|
EVC2, LOC126806961
|
0 |
6
|
0 |
0 |
0 |
6
|
|
F9
|
1
|
5
|
0 |
0 |
0 |
6
|
|
GBE1
|
3
|
3
|
0 |
0 |
0 |
6
|
|
GLA, RPL36A-HNRNPH2
|
1
|
5
|
0 |
0 |
0 |
6
|
|
IL2RG
|
0 |
6
|
0 |
0 |
0 |
6
|
|
MVK
|
2
|
4
|
0 |
0 |
0 |
6
|
|
PHYH
|
0 |
6
|
0 |
0 |
0 |
6
|
|
PYGM
|
1
|
5
|
0 |
0 |
0 |
6
|
|
SEPSECS
|
4
|
2
|
0 |
0 |
0 |
6
|
|
SGCG
|
0 |
5
|
1
|
0 |
0 |
6
|
|
TTPA
|
3
|
3
|
0 |
0 |
0 |
6
|
|
XPC
|
2
|
3
|
1
|
0 |
0 |
6
|
|
ACAT1
|
1
|
4
|
0 |
0 |
0 |
5
|
|
ADA, LOC107303343
|
0 |
5
|
0 |
0 |
0 |
5
|
|
AGA
|
2
|
3
|
0 |
0 |
0 |
5
|
|
BCHE
|
1
|
4
|
0 |
0 |
0 |
5
|
|
CERKL
|
4
|
1
|
0 |
0 |
0 |
5
|
|
CLN5
|
4
|
1
|
0 |
0 |
0 |
5
|
|
CLN8
|
2
|
2
|
1
|
0 |
0 |
5
|
|
CYP27B1
|
1
|
4
|
0 |
0 |
0 |
5
|
|
EYS, PHF3
|
3
|
2
|
0 |
0 |
0 |
5
|
|
FAM161A
|
5
|
0 |
0 |
0 |
0 |
5
|
|
FANCA, ZNF276
|
4
|
1
|
0 |
0 |
0 |
5
|
|
FKRP
|
3
|
2
|
0 |
0 |
0 |
5
|
|
HBB, LOC107133510, LOC110006319
|
4
|
1
|
0 |
0 |
0 |
5
|
|
HOGA1
|
2
|
3
|
0 |
0 |
0 |
5
|
|
IDUA, SLC26A1
|
1
|
4
|
0 |
0 |
0 |
5
|
|
LOC123956210, SLC26A4
|
1
|
3
|
1
|
0 |
0 |
5
|
|
LOC130003710, RET
|
0 |
0 |
0 |
3
|
2
|
5
|
|
MCCC2
|
2
|
3
|
0 |
0 |
0 |
5
|
|
OCA2
|
3
|
2
|
0 |
0 |
0 |
5
|
|
SMARCA4
|
2
|
0 |
0 |
1
|
2
|
5
|
|
SUMF1
|
0 |
5
|
0 |
0 |
0 |
5
|
|
ABCD1, PLXNB3
|
1
|
3
|
0 |
0 |
0 |
4
|
|
AMT
|
2
|
2
|
0 |
0 |
0 |
4
|
|
ATP6V1B1
|
2
|
2
|
0 |
0 |
0 |
4
|
|
AXDND1, NPHS2
|
3
|
1
|
0 |
0 |
0 |
4
|
|
C17orf107, CHRNE
|
2
|
2
|
0 |
0 |
0 |
4
|
|
CHRNE
|
2
|
2
|
0 |
0 |
0 |
4
|
|
DPYD
|
2
|
2
|
0 |
0 |
0 |
4
|
|
ERCC6, LOC126860933
|
0 |
4
|
0 |
0 |
0 |
4
|
|
FANCA, LOC112486223
|
2
|
2
|
0 |
0 |
0 |
4
|
|
GALT, LOC130001683
|
0 |
3
|
1
|
0 |
0 |
4
|
|
GCDH, LOC117125594
|
0 |
4
|
0 |
0 |
0 |
4
|
|
IDS
|
1
|
3
|
0 |
0 |
0 |
4
|
|
LAMA2, LOC123864065
|
0 |
4
|
0 |
0 |
0 |
4
|
|
MTHFR
|
2
|
2
|
0 |
0 |
0 |
4
|
|
OAT
|
2
|
2
|
0 |
0 |
0 |
4
|
|
RNASEH2B
|
2
|
2
|
0 |
0 |
0 |
4
|
|
SGCB
|
1
|
3
|
0 |
0 |
0 |
4
|
|
TYMP
|
4
|
0 |
0 |
0 |
0 |
4
|
|
XPA
|
2
|
2
|
0 |
0 |
0 |
4
|
|
ABCA3
|
0 |
3
|
0 |
0 |
0 |
3
|
|
ANO10
|
3
|
0 |
0 |
0 |
0 |
3
|
|
CC2D2A
|
1
|
2
|
0 |
0 |
0 |
3
|
|
CEP290, RLIG1
|
3
|
0 |
0 |
0 |
0 |
3
|
|
CYBA
|
0 |
3
|
0 |
0 |
0 |
3
|
|
FBXO11, MSH6
|
1
|
0 |
0 |
2
|
0 |
3
|
|
GCDH, LOC126862860, SYCE2
|
2
|
1
|
0 |
0 |
0 |
3
|
|
HPS1
|
2
|
1
|
0 |
0 |
0 |
3
|
|
LOC126861615, PAH
|
2
|
1
|
0 |
0 |
0 |
3
|
|
LOC129391064, MAN2B1
|
0 |
3
|
0 |
0 |
0 |
3
|
|
LOC129929541, SDHB
|
0 |
0 |
0 |
2
|
1
|
3
|
|
MEFV
|
2
|
1
|
0 |
0 |
0 |
3
|
|
PEX12
|
3
|
0 |
0 |
0 |
0 |
3
|
|
PROP1
|
2
|
1
|
0 |
0 |
0 |
3
|
|
RB1
|
0 |
0 |
0 |
0 |
3
|
3
|
|
SERPINA1
|
1
|
2
|
0 |
0 |
0 |
3
|
|
SGCD
|
2
|
1
|
0 |
0 |
0 |
3
|
|
ACADVL, DVL2
|
0 |
2
|
0 |
0 |
0 |
2
|
|
AHI1
|
1
|
1
|
0 |
0 |
0 |
2
|
|
ALMS1, LOC126806252
|
0 |
2
|
0 |
0 |
0 |
2
|
|
APBB1, SMPD1
|
2
|
0 |
0 |
0 |
0 |
2
|
|
ARG1
|
0 |
2
|
0 |
0 |
0 |
2
|
|
ASNS, CZ1P-ASNS
|
0 |
2
|
0 |
0 |
0 |
2
|
|
BBS12
|
2
|
0 |
0 |
0 |
0 |
2
|
|
CHRNE, LOC130060041
|
1
|
1
|
0 |
0 |
0 |
2
|
|
CPT2, LOC129930561
|
0 |
2
|
0 |
0 |
0 |
2
|
|
CYP21A2, LOC106780800, TNXB
|
2
|
0 |
0 |
0 |
0 |
2
|
|
FANCA, LOC130059837
|
1
|
1
|
0 |
0 |
0 |
2
|
|
FANCA, LOC132090450
|
1
|
0 |
1
|
0 |
0 |
2
|
|
FMO3
|
0 |
2
|
0 |
0 |
0 |
2
|
|
GBA1
|
2
|
0 |
0 |
0 |
0 |
2
|
|
GNPTG, LOC130058158
|
0 |
2
|
0 |
0 |
0 |
2
|
|
HFE
|
2
|
0 |
0 |
0 |
0 |
2
|
|
KCNJ11
|
1
|
1
|
0 |
0 |
0 |
2
|
|
LOC111413029, TAT
|
0 |
2
|
0 |
0 |
0 |
2
|
|
LOC125446261, MLC1
|
0 |
1
|
1
|
0 |
0 |
2
|
|
LOC126862264, MEFV
|
2
|
0 |
0 |
0 |
0 |
2
|
|
LOC129992585, SGCB
|
1
|
1
|
0 |
0 |
0 |
2
|
|
LOC130063648, MAN2B1
|
0 |
2
|
0 |
0 |
0 |
2
|
|
LOC130067862, SCO2, TYMP
|
2
|
0 |
0 |
0 |
0 |
2
|
|
LOC132090059, PUS1
|
0 |
2
|
0 |
0 |
0 |
2
|
|
MESP2
|
1
|
1
|
0 |
0 |
0 |
2
|
|
RAG2
|
2
|
0 |
0 |
0 |
0 |
2
|
|
RAPSN
|
1
|
1
|
0 |
0 |
0 |
2
|
|
RTEL1, RTEL1-TNFRSF6B
|
2
|
0 |
0 |
0 |
0 |
2
|
|
SLC19A3
|
2
|
0 |
0 |
0 |
0 |
2
|
|
VPS13A
|
1
|
1
|
0 |
0 |
0 |
2
|
|
ABCC8, LOC110121471
|
0 |
1
|
0 |
0 |
0 |
1
|
|
ACYP1, NPC2
|
0 |
0 |
1
|
0 |
0 |
1
|
|
AMT, NICN1
|
0 |
0 |
1
|
0 |
0 |
1
|
|
ARX
|
1
|
0 |
0 |
0 |
0 |
1
|
|
BAP1, DNAH1
|
1
|
0 |
0 |
0 |
0 |
1
|
|
BRCA1, LOC111589215
|
0 |
0 |
0 |
1
|
0 |
1
|
|
CAPN3, LOC130056921
|
0 |
1
|
0 |
0 |
0 |
1
|
|
CARD14, SGSH
|
1
|
0 |
0 |
0 |
0 |
1
|
|
CC2D2A, FBXL5
|
0 |
1
|
0 |
0 |
0 |
1
|
|
CCDC107, RMRP
|
1
|
0 |
0 |
0 |
0 |
1
|
|
CFTR, LOC113633877
|
1
|
0 |
0 |
0 |
0 |
1
|
|
CFTR, LOC113664106
|
1
|
0 |
0 |
0 |
0 |
1
|
|
COL4A3, COL4A4, LOC129935730
|
1
|
0 |
0 |
0 |
0 |
1
|
|
DCTN5, PALB2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
DDX25, HYLS1, PUS3
|
1
|
0 |
0 |
0 |
0 |
1
|
|
DHDDS
|
1
|
0 |
0 |
0 |
0 |
1
|
|
DNAH5, LOC107457585
|
0 |
1
|
0 |
0 |
0 |
1
|
|
DNAI2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
ERCC8, NDUFAF2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
HBA1, HBA2, LOC106804612
|
1
|
0 |
0 |
0 |
0 |
1
|
|
HBB, LOC106099062, LOC107133510, LOC110006319
|
1
|
0 |
0 |
0 |
0 |
1
|
|
HSD17B4, LOC129994460
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC126806373, NEB
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC126860438, NBN
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC126862097, SLC12A6
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC129930446, MMACHC
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC129936056, SUMF1
|
1
|
0 |
0 |
0 |
0 |
1
|
|
LOC129998796, PEX1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC130009366, SACS
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC130060903, NAGLU
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC130061900, SGSH
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC130063376, MCOLN1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LOC130067864, TYMP
|
1
|
0 |
0 |
0 |
0 |
1
|
|
LOC132089454, SLC17A5
|
0 |
1
|
0 |
0 |
0 |
1
|
|
LRP2
|
0 |
1
|
0 |
0 |
0 |
1
|
|
MCPH1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
MIR6753, TCIRG1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
NCAPH2, SCO2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
NDUFS4
|
0 |
1
|
0 |
0 |
0 |
1
|
|
NTHL1, TSC2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
OPA3
|
1
|
0 |
0 |
0 |
0 |
1
|
|
PEX2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
PHGDH
|
0 |
1
|
0 |
0 |
0 |
1
|
|
POLG, POLGARF
|
1
|
0 |
0 |
0 |
0 |
1
|
|
PTS
|
0 |
1
|
0 |
0 |
0 |
1
|
|
RPGR
|
1
|
0 |
0 |
0 |
0 |
1
|
|
RS1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
SGSH, SLC26A11
|
1
|
0 |
0 |
0 |
0 |
1
|
|
TECPR2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
TMEM216
|
1
|
0 |
0 |
0 |
0 |
1
|
|
TRMU
|
0 |
1
|
0 |
0 |
0 |
1
|
|
VRK1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
VSX2
|
1
|
0 |
0 |
0 |
0 |
1
|
Condition and significance breakdown #
| Condition |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
|
Familial cancer of breast
|
3001
|
711
|
241
|
1853
|
4295
|
10101
|
|
Familial adenomatous polyposis 1
|
1270
|
82
|
146
|
287
|
1859
|
3644
|
|
Lynch syndrome 5
|
937
|
115
|
94
|
314
|
1315
|
2775
|
|
Tuberous sclerosis 2
|
12
|
9
|
0 |
729
|
1487
|
2237
|
|
Lynch syndrome 1
|
720
|
189
|
55
|
391
|
788
|
2143
|
|
Hereditary diffuse gastric adenocarcinoma
|
287
|
90
|
85
|
426
|
1065
|
1953
|
|
Colorectal cancer, hereditary nonpolyposis, type 2
|
639
|
154
|
27
|
315
|
599
|
1734
|
|
Lynch syndrome 4
|
333
|
113
|
69
|
232
|
757
|
1504
|
|
Li-Fraumeni syndrome 1
|
165
|
259
|
39
|
131
|
293
|
887
|
|
Oligodontia-cancer predisposition syndrome
|
47
|
5
|
0 |
145
|
652
|
849
|
|
Cowden syndrome 1
|
309
|
119
|
12
|
120
|
262
|
822
|
|
Tuberous sclerosis 1
|
22
|
9
|
0 |
242
|
516
|
789
|
|
Peutz-Jeghers syndrome
|
36
|
12
|
43
|
147
|
481
|
719
|
|
Pheochromocytoma/paraganglioma syndrome 5
|
79
|
47
|
30
|
156
|
397
|
709
|
|
Papillary renal cell carcinoma type 1
|
0 |
1
|
0 |
172
|
529
|
702
|
|
Breast-ovarian cancer, familial, susceptibility to, 3
|
106
|
108
|
12
|
133
|
272
|
631
|
|
BAP1-related tumor predisposition syndrome
|
60
|
15
|
0 |
181
|
348
|
604
|
|
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome
|
41
|
13
|
15
|
127
|
373
|
569
|
|
Juvenile polyposis syndrome
|
57
|
14
|
17
|
139
|
337
|
564
|
|
Breast-ovarian cancer, familial, susceptibility to, 4
|
79
|
52
|
12
|
145
|
259
|
547
|
|
Birt-Hogg-Dube syndrome 1
|
22
|
6
|
0 |
171
|
297
|
496
|
|
Breast-ovarian cancer, familial, susceptibility to, 2
|
308
|
20
|
0 |
114
|
25
|
467
|
|
Multiple endocrine neoplasia, type 1
|
26
|
10
|
2
|
87
|
305
|
430
|
|
Hereditary leiomyomatosis and renal cell cancer
|
49
|
45
|
1
|
84
|
222
|
401
|
|
Multiple endocrine neoplasia type 2A
|
23
|
6
|
20
|
117
|
228
|
394
|
|
Colorectal cancer, susceptibility to, 10
|
0 |
3
|
6
|
124
|
237
|
370
|
|
Melanoma-pancreatic cancer syndrome
|
32
|
30
|
19
|
28
|
227
|
336
|
|
Melanoma, cutaneous malignant, susceptibility to, 3
|
0 |
0 |
6
|
83
|
233
|
322
|
|
Familial adenomatous polyposis 4
|
250
|
58
|
0 |
2
|
2
|
312
|
|
Breast-ovarian cancer, familial, susceptibility to, 1
|
132
|
25
|
4
|
111
|
24
|
296
|
|
Von Hippel-Lindau syndrome
|
22
|
12
|
1
|
63
|
173
|
271
|
|
Colorectal cancer, susceptibility to, 12
|
0 |
0 |
13
|
95
|
161
|
269
|
|
Prostate cancer, hereditary, 9
|
0 |
0 |
0 |
17
|
231
|
248
|
|
Pheochromocytoma/paraganglioma syndrome 4
|
42
|
21
|
5
|
59
|
120
|
247
|
|
Nemaline myopathy 2
|
6
|
203
|
0 |
0 |
0 |
209
|
|
Primary ciliary dyskinesia 3
|
4
|
199
|
0 |
0 |
0 |
203
|
|
LAMA2-related muscular dystrophy
|
6
|
165
|
3
|
0 |
0 |
174
|
|
Pheochromocytoma/paraganglioma syndrome 3
|
21
|
10
|
4
|
45
|
91
|
171
|
|
Autosomal recessive Alport syndrome
|
1
|
150
|
3
|
0 |
0 |
154
|
|
Lung cancer
|
0 |
1
|
0 |
47
|
102
|
150
|
|
Cystic fibrosis
|
77
|
72
|
0 |
0 |
0 |
149
|
|
Polycystic kidney disease 4
|
3
|
123
|
2
|
0 |
0 |
128
|
|
Pheochromocytoma/paraganglioma syndrome 1
|
14
|
2
|
0 |
30
|
80
|
126
|
|
Usher syndrome type 1
|
6
|
95
|
6
|
0 |
0 |
107
|
|
Autosomal recessive limb-girdle muscular dystrophy
|
7
|
91
|
3
|
0 |
0 |
101
|
|
Hereditary spastic paraplegia 15
|
1
|
99
|
1
|
0 |
0 |
101
|
|
Ellis-van Creveld syndrome
|
4
|
93
|
1
|
0 |
0 |
98
|
|
Usher syndrome type 2A
|
7
|
72
|
14
|
0 |
0 |
93
|
|
Familial adenomatous polyposis 3
|
74
|
14
|
0 |
1
|
0 |
89
|
|
Glycogen storage disease type III
|
2
|
74
|
0 |
0 |
0 |
76
|
|
X-linked Alport syndrome
|
2
|
73
|
0 |
0 |
0 |
75
|
|
Wilson disease
|
11
|
56
|
6
|
0 |
0 |
73
|
|
Congenital hyperammonemia, type I
|
1
|
68
|
1
|
0 |
0 |
70
|
|
GNPTAB-mucolipidosis
|
2
|
66
|
0 |
0 |
0 |
68
|
|
Niemann-Pick disease, type C1
|
4
|
62
|
2
|
0 |
0 |
68
|
|
Progressive muscular dystrophy
|
7
|
60
|
0 |
0 |
0 |
67
|
|
Junctional epidermolysis bullosa gravis of Herlitz
|
4
|
62
|
0 |
0 |
0 |
66
|
|
Peroxisome biogenesis disorder
|
7
|
58
|
1
|
0 |
0 |
66
|
|
Cockayne syndrome type 2
|
0 |
65
|
0 |
0 |
0 |
65
|
|
Glycine encephalopathy
|
2
|
56
|
4
|
0 |
0 |
62
|
|
Menkes kinky-hair syndrome
|
0 |
61
|
0 |
0 |
0 |
61
|
|
Fanconi anemia complementation group A
|
16
|
43
|
1
|
0 |
0 |
60
|
|
Birt-Hogg-Dube syndrome
|
44
|
11
|
0 |
1
|
3
|
59
|
|
Alstrom syndrome
|
0 |
58
|
0 |
0 |
0 |
58
|
|
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type
|
0 |
58
|
0 |
0 |
0 |
58
|
|
Deficiency of alpha-mannosidase
|
3
|
53
|
0 |
0 |
0 |
56
|
|
Maple syrup urine disease
|
3
|
50
|
2
|
0 |
0 |
55
|
|
Pendred syndrome
|
15
|
30
|
10
|
0 |
0 |
55
|
|
Phenylketonuria
|
25
|
29
|
0 |
0 |
0 |
54
|
|
Abetalipoproteinaemia
|
1
|
50
|
0 |
0 |
0 |
51
|
|
Familial dysautonomia
|
3
|
48
|
0 |
0 |
0 |
51
|
|
Finnish congenital nephrotic syndrome
|
5
|
38
|
5
|
0 |
0 |
48
|
|
Hyperinsulinemic hypoglycemia, familial, 1
|
4
|
38
|
6
|
0 |
0 |
48
|
|
Usher syndrome type 1D
|
1
|
41
|
5
|
0 |
0 |
47
|
|
Glycogen storage disease, type II
|
13
|
30
|
3
|
0 |
0 |
46
|
|
Bloom syndrome
|
33
|
7
|
0 |
2
|
3
|
45
|
|
Charlevoix-Saguenay spastic ataxia
|
19
|
26
|
0 |
0 |
0 |
45
|
|
Tay-Sachs disease
|
9
|
34
|
1
|
0 |
0 |
44
|
|
Cohen syndrome
|
11
|
31
|
1
|
0 |
0 |
43
|
|
Junctional epidermolysis bullosa
|
4
|
38
|
0 |
0 |
0 |
42
|
|
Sessile serrated polyposis cancer syndrome
|
33
|
6
|
0 |
0 |
2
|
41
|
|
Very long chain acyl-CoA dehydrogenase deficiency
|
7
|
26
|
8
|
0 |
0 |
41
|
|
Holocarboxylase synthetase deficiency
|
0 |
39
|
1
|
0 |
0 |
40
|
|
Pyruvate carboxylase deficiency
|
0 |
39
|
0 |
0 |
0 |
39
|
|
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
|
5
|
31
|
2
|
0 |
0 |
38
|
|
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
|
1
|
34
|
1
|
0 |
0 |
36
|
|
Autosomal recessive nonsyndromic hearing loss 77
|
7
|
27
|
1
|
0 |
0 |
35
|
|
Hereditary factor VIII deficiency disease
|
16
|
19
|
0 |
0 |
0 |
35
|
|
Hermansky-Pudlak syndrome 3
|
1
|
34
|
0 |
0 |
0 |
35
|
|
Propionic acidemia
|
2
|
32
|
1
|
0 |
0 |
35
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2A
|
9
|
23
|
2
|
0 |
0 |
34
|
|
Bardet-Biedl syndrome 2
|
2
|
30
|
2
|
0 |
0 |
34
|
|
Agenesis of the corpus callosum with peripheral neuropathy
|
2
|
31
|
0 |
0 |
0 |
33
|
|
Familial adenomatous polyposis 2
|
16
|
16
|
0 |
1
|
0 |
33
|
|
USH2A-related disorder
|
19
|
14
|
0 |
0 |
0 |
33
|
|
Congenital amegakaryocytic thrombocytopenia
|
0 |
31
|
0 |
0 |
0 |
31
|
|
Bifunctional peroxisomal enzyme deficiency
|
0 |
28
|
1
|
0 |
0 |
29
|
|
Galactosylceramide beta-galactosidase deficiency
|
5
|
22
|
1
|
0 |
0 |
28
|
|
Argininosuccinate lyase deficiency
|
4
|
22
|
1
|
0 |
0 |
27
|
|
Autosomal recessive congenital ichthyosis 1
|
4
|
21
|
2
|
0 |
0 |
27
|
|
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
|
2
|
25
|
0 |
0 |
0 |
27
|
|
Mucopolysaccharidosis, MPS-III-C
|
5
|
20
|
2
|
0 |
0 |
27
|
|
PMM2-congenital disorder of glycosylation
|
8
|
18
|
1
|
0 |
0 |
27
|
|
beta Thalassemia
|
21
|
6
|
0 |
0 |
0 |
27
|
|
Classic homocystinuria
|
4
|
20
|
2
|
0 |
0 |
26
|
|
GNE myopathy
|
7
|
19
|
0 |
0 |
0 |
26
|
|
Sandhoff disease
|
1
|
25
|
0 |
0 |
0 |
26
|
|
Smith-Lemli-Opitz syndrome
|
8
|
18
|
0 |
0 |
0 |
26
|
|
Glycogen storage disease, type VII
|
1
|
24
|
0 |
0 |
0 |
25
|
|
Mucopolysaccharidosis, MPS-I-H/S
|
1
|
24
|
0 |
0 |
0 |
25
|
|
Alport syndrome
|
5
|
19
|
0 |
0 |
0 |
24
|
|
Colorectal cancer, hereditary nonpolyposis, type 7
|
22
|
2
|
0 |
0 |
0 |
24
|
|
Ehlers-Danlos syndrome, dermatosparaxis type
|
1
|
22
|
0 |
0 |
0 |
23
|
|
Severe X-linked myotubular myopathy
|
0 |
23
|
0 |
0 |
0 |
23
|
|
Usher syndrome type 1C
|
3
|
18
|
2
|
0 |
0 |
23
|
|
Cholestanol storage disease
|
5
|
17
|
0 |
0 |
0 |
22
|
|
Fanconi anemia complementation group C
|
3
|
19
|
0 |
0 |
0 |
22
|
|
Glutaric aciduria, type 1
|
8
|
14
|
0 |
0 |
0 |
22
|
|
Metachromatic leukodystrophy
|
7
|
15
|
0 |
0 |
0 |
22
|
|
Microcephaly, normal intelligence and immunodeficiency
|
0 |
22
|
0 |
0 |
0 |
22
|
|
Primary hyperoxaluria, type I
|
3
|
18
|
1
|
0 |
0 |
22
|
|
Achromatopsia 3
|
1
|
18
|
2
|
0 |
0 |
21
|
|
Autosomal recessive nonsyndromic hearing loss 1A
|
15
|
1
|
5
|
0 |
0 |
21
|
|
Bardet-Biedl syndrome 1
|
1
|
18
|
2
|
0 |
0 |
21
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
|
2
|
19
|
0 |
0 |
0 |
21
|
|
Polyglandular autoimmune syndrome, type 1
|
5
|
16
|
0 |
0 |
0 |
21
|
|
Pyruvate dehydrogenase E3 deficiency
|
3
|
18
|
0 |
0 |
0 |
21
|
|
Retinitis pigmentosa 25
|
13
|
8
|
0 |
0 |
0 |
21
|
|
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency
|
2
|
19
|
0 |
0 |
0 |
21
|
|
Sjögren-Larsson syndrome
|
2
|
19
|
0 |
0 |
0 |
21
|
|
Lysosomal acid lipase deficiency
|
6
|
14
|
0 |
0 |
0 |
20
|
|
Peroxisome biogenesis disorder 4A (Zellweger)
|
0 |
20
|
0 |
0 |
0 |
20
|
|
Renal carnitine transport defect
|
5
|
13
|
2
|
0 |
0 |
20
|
|
Carnitine palmitoyl transferase 1A deficiency
|
3
|
16
|
0 |
0 |
0 |
19
|
|
Deficiency of galactokinase
|
2
|
16
|
1
|
0 |
0 |
19
|
|
Hereditary factor XI deficiency disease
|
1
|
16
|
2
|
0 |
0 |
19
|
|
Neuronal ceroid lipofuscinosis 2
|
4
|
15
|
0 |
0 |
0 |
19
|
|
Autosomal recessive osteopetrosis 1
|
4
|
13
|
1
|
0 |
0 |
18
|
|
CEP290-related ciliopathy
|
18
|
0 |
0 |
0 |
0 |
18
|
|
Ciliopathy
|
0 |
18
|
0 |
0 |
0 |
18
|
|
Deficiency of steroid 11-beta-monooxygenase
|
0 |
17
|
1
|
0 |
0 |
18
|
|
GLB1-related disorder
|
1
|
17
|
0 |
0 |
0 |
18
|
|
Medium-chain acyl-coenzyme A dehydrogenase deficiency
|
4
|
14
|
0 |
0 |
0 |
18
|
|
Megalencephalic leukoencephalopathy with subcortical cysts 1
|
1
|
16
|
1
|
0 |
0 |
18
|
|
ALG6-congenital disorder of glycosylation 1C
|
0 |
16
|
1
|
0 |
0 |
17
|
|
Autosomal recessive DOPA responsive dystonia
|
1
|
16
|
0 |
0 |
0 |
17
|
|
Nephrotic syndrome, type 2
|
6
|
10
|
1
|
0 |
0 |
17
|
|
Recessive dystrophic epidermolysis bullosa
|
10
|
7
|
0 |
0 |
0 |
17
|
|
Acid sphingomyelinase deficiency
|
3
|
9
|
4
|
0 |
0 |
16
|
|
Congenital lipoid adrenal hyperplasia due to STAR deficency
|
1
|
15
|
0 |
0 |
0 |
16
|
|
Isovaleryl-CoA dehydrogenase deficiency
|
3
|
12
|
1
|
0 |
0 |
16
|
|
Neurofibromatosis, type 1
|
13
|
3
|
0 |
0 |
0 |
16
|
|
Oculocutaneous albinism type 1
|
5
|
11
|
0 |
0 |
0 |
16
|
|
Tyrosinemia type I
|
6
|
10
|
0 |
0 |
0 |
16
|
|
Cockayne syndrome type 1
|
2
|
13
|
0 |
0 |
0 |
15
|
|
Hereditary fructosuria
|
3
|
9
|
3
|
0 |
0 |
15
|
|
Hypophosphatasia
|
2
|
12
|
1
|
0 |
0 |
15
|
|
Mucopolysaccharidosis, MPS-III-A
|
4
|
10
|
1
|
0 |
0 |
15
|
|
Neuronal ceroid lipofuscinosis
|
7
|
8
|
0 |
0 |
0 |
15
|
|
Pyknodysostosis
|
1
|
14
|
0 |
0 |
0 |
15
|
|
Rhizomelic chondrodysplasia punctata type 1
|
2
|
13
|
0 |
0 |
0 |
15
|
|
Asphyxiating thoracic dystrophy 3
|
7
|
7
|
0 |
0 |
0 |
14
|
|
Biotinidase deficiency
|
7
|
6
|
1
|
0 |
0 |
14
|
|
Citrullinemia type I
|
2
|
11
|
1
|
0 |
0 |
14
|
|
Deficiency of hydroxymethylglutaryl-CoA lyase
|
3
|
9
|
2
|
0 |
0 |
14
|
|
Niemann-Pick disease, type C2
|
0 |
13
|
1
|
0 |
0 |
14
|
|
Alkaptonuria
|
3
|
10
|
0 |
0 |
0 |
13
|
|
Arginase deficiency
|
2
|
11
|
0 |
0 |
0 |
13
|
|
Mucolipidosis type IV
|
1
|
12
|
0 |
0 |
0 |
13
|
|
Myopathy caused by variation in FKTN
|
0 |
13
|
0 |
0 |
0 |
13
|
|
Primary hyperoxaluria, type II
|
1
|
12
|
0 |
0 |
0 |
13
|
|
Sialic acid storage disease, severe infantile type
|
0 |
13
|
0 |
0 |
0 |
13
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2D
|
3
|
8
|
1
|
0 |
0 |
12
|
|
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA
|
7
|
5
|
0 |
0 |
0 |
12
|
|
Methylmalonic aciduria, cblA type
|
1
|
11
|
0 |
0 |
0 |
12
|
|
Methylmalonic aciduria, cblB type
|
9
|
3
|
0 |
0 |
0 |
12
|
|
Mucopolysaccharidosis, MPS-III-B
|
2
|
10
|
0 |
0 |
0 |
12
|
|
Tumor predisposition syndrome 2
|
10
|
2
|
0 |
0 |
0 |
12
|
|
BCS1L-related disorder
|
2
|
8
|
1
|
0 |
0 |
11
|
|
Mucopolysaccharidosis, MPS-II
|
1
|
10
|
0 |
0 |
0 |
11
|
|
Ornithine carbamoyltransferase deficiency
|
3
|
8
|
0 |
0 |
0 |
11
|
|
Adrenoleukodystrophy
|
2
|
8
|
0 |
0 |
0 |
10
|
|
Congenital myasthenic syndrome
|
5
|
5
|
0 |
0 |
0 |
10
|
|
Deficiency of butyryl-CoA dehydrogenase
|
1
|
9
|
0 |
0 |
0 |
10
|
|
GNPTG-mucolipidosis
|
0 |
9
|
1
|
0 |
0 |
10
|
|
Neuronal ceroid lipofuscinosis 3
|
0 |
9
|
1
|
0 |
0 |
10
|
|
Spongy degeneration of central nervous system
|
4
|
6
|
0 |
0 |
0 |
10
|
|
Bardet-Biedl syndrome 10
|
5
|
1
|
3
|
0 |
0 |
9
|
|
Choroideremia
|
2
|
7
|
0 |
0 |
0 |
9
|
|
Cobalamin C disease
|
1
|
7
|
1
|
0 |
0 |
9
|
|
Gaucher disease type I
|
6
|
3
|
0 |
0 |
0 |
9
|
|
Neuronal ceroid lipofuscinosis 1
|
4
|
5
|
0 |
0 |
0 |
9
|
|
Tyrosinemia type II
|
0 |
9
|
0 |
0 |
0 |
9
|
|
21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
|
8
|
0 |
0 |
0 |
0 |
8
|
|
Cystinosis
|
2
|
6
|
0 |
0 |
0 |
8
|
|
ERCC2-related disorder
|
3
|
5
|
0 |
0 |
0 |
8
|
|
Familial hemophagocytic lymphohistiocytosis 2
|
4
|
4
|
0 |
0 |
0 |
8
|
|
POLG-related disorder
|
2
|
6
|
0 |
0 |
0 |
8
|
|
Carnitine palmitoyltransferase II deficiency
|
2
|
4
|
1
|
0 |
0 |
7
|
|
Ehlers-Danlos syndrome due to tenascin-X deficiency
|
7
|
0 |
0 |
0 |
0 |
7
|
|
Hereditary insensitivity to pain with anhidrosis
|
6
|
1
|
0 |
0 |
0 |
7
|
|
Juvenile retinoschisis
|
4
|
3
|
0 |
0 |
0 |
7
|
|
Mitochondrial DNA depletion syndrome 1
|
7
|
0 |
0 |
0 |
0 |
7
|
|
Nonsyndromic genetic hearing loss
|
1
|
6
|
0 |
0 |
0 |
7
|
|
RPE65-related recessive retinopathy
|
4
|
3
|
0 |
0 |
0 |
7
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2C
|
0 |
5
|
1
|
0 |
0 |
6
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2E
|
2
|
4
|
0 |
0 |
0 |
6
|
|
Autosomal recessive polycystic kidney disease
|
6
|
0 |
0 |
0 |
0 |
6
|
|
BBS2-related ciliopathy
|
0 |
6
|
0 |
0 |
0 |
6
|
|
Deficiency of mevalonate kinase
|
2
|
4
|
0 |
0 |
0 |
6
|
|
Enhanced S-cone syndrome
|
4
|
2
|
0 |
0 |
0 |
6
|
|
Fabry disease
|
1
|
5
|
0 |
0 |
0 |
6
|
|
Familial isolated deficiency of vitamin E
|
3
|
3
|
0 |
0 |
0 |
6
|
|
Glycogen storage disease, type IV
|
3
|
3
|
0 |
0 |
0 |
6
|
|
Glycogen storage disease, type V
|
1
|
5
|
0 |
0 |
0 |
6
|
|
Hereditary factor IX deficiency disease
|
1
|
5
|
0 |
0 |
0 |
6
|
|
Multiple sulfatase deficiency
|
1
|
5
|
0 |
0 |
0 |
6
|
|
Phytanic acid storage disease
|
0 |
6
|
0 |
0 |
0 |
6
|
|
Pontocerebellar hypoplasia type 2D
|
4
|
2
|
0 |
0 |
0 |
6
|
|
Usher syndrome type 1F
|
3
|
3
|
0 |
0 |
0 |
6
|
|
X-linked severe combined immunodeficiency
|
0 |
6
|
0 |
0 |
0 |
6
|
|
Xeroderma pigmentosum, group C
|
2
|
3
|
1
|
0 |
0 |
6
|
|
3-methylcrotonyl-CoA carboxylase 2 deficiency
|
2
|
3
|
0 |
0 |
0 |
5
|
|
Aspartylglucosaminuria
|
2
|
3
|
0 |
0 |
0 |
5
|
|
Deficiency of acetyl-CoA acetyltransferase
|
1
|
4
|
0 |
0 |
0 |
5
|
|
Deficiency of butyrylcholinesterase
|
1
|
4
|
0 |
0 |
0 |
5
|
|
Familial Mediterranean fever
|
4
|
1
|
0 |
0 |
0 |
5
|
|
Familial ovarian cancer
|
2
|
3
|
0 |
0 |
0 |
5
|
|
Glycine encephalopathy 1
|
0 |
5
|
0 |
0 |
0 |
5
|
|
Mucopolysaccharidosis type 1
|
2
|
3
|
0 |
0 |
0 |
5
|
|
Neuronal ceroid lipofuscinosis 5
|
4
|
1
|
0 |
0 |
0 |
5
|
|
Primary hyperoxaluria type 3
|
2
|
3
|
0 |
0 |
0 |
5
|
|
Retinitis pigmentosa 26
|
4
|
1
|
0 |
0 |
0 |
5
|
|
Retinitis pigmentosa 28
|
5
|
0 |
0 |
0 |
0 |
5
|
|
Rhabdoid tumor predisposition syndrome 2
|
2
|
0 |
0 |
1
|
2
|
5
|
|
Tyrosinase-positive oculocutaneous albinism
|
3
|
2
|
0 |
0 |
0 |
5
|
|
Vitamin D-dependent rickets, type 1A
|
1
|
4
|
0 |
0 |
0 |
5
|
|
3MC syndrome 2
|
3
|
1
|
0 |
0 |
0 |
4
|
|
Achondrogenesis, type IB
|
3
|
1
|
0 |
0 |
0 |
4
|
|
Aicardi-Goutieres syndrome 2
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Diastrophic dysplasia
|
3
|
1
|
0 |
0 |
0 |
4
|
|
Dihydropyrimidine dehydrogenase deficiency
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Glucose-6-phosphate transport defect
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Homocystinuria due to methylene tetrahydrofolate reductase deficiency
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Joubert syndrome and related disorders
|
1
|
3
|
0 |
0 |
0 |
4
|
|
Maple syrup urine disease type 1A
|
0 |
4
|
0 |
0 |
0 |
4
|
|
Multiple epiphyseal dysplasia type 4
|
3
|
1
|
0 |
0 |
0 |
4
|
|
Myopathy caused by variation in FKRP
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Myopathy caused by variation in POMGNT1
|
1
|
3
|
0 |
0 |
0 |
4
|
|
Niemann-Pick disease, type A
|
4
|
0 |
0 |
0 |
0 |
4
|
|
Ornithine aminotransferase deficiency
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Renal tubular acidosis with progressive nerve deafness
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Xeroderma pigmentosum group A
|
2
|
2
|
0 |
0 |
0 |
4
|
|
Alpha-1-antitrypsin deficiency
|
1
|
2
|
0 |
0 |
0 |
3
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2F
|
2
|
1
|
0 |
0 |
0 |
3
|
|
Autosomal recessive spinocerebellar ataxia 10
|
3
|
0 |
0 |
0 |
0 |
3
|
|
Carnitine palmitoyl transferase II deficiency, severe infantile form
|
3
|
0 |
0 |
0 |
0 |
3
|
|
Glycine encephalopathy 2
|
1
|
2
|
0 |
0 |
0 |
3
|
|
Glycogen storage disease, type I
|
3
|
0 |
0 |
0 |
0 |
3
|
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
0 |
3
|
0 |
0 |
0 |
3
|
|
Hermansky-Pudlak syndrome 1
|
2
|
1
|
0 |
0 |
0 |
3
|
|
Infantile hypophosphatasia
|
2
|
1
|
0 |
0 |
0 |
3
|
|
Interstitial lung disease due to ABCA3 deficiency
|
0 |
3
|
0 |
0 |
0 |
3
|
|
Pituitary hormone deficiency, combined, 2
|
2
|
1
|
0 |
0 |
0 |
3
|
|
Retinoblastoma
|
0 |
0 |
0 |
0 |
3
|
3
|
|
SLC26A2-related skeletal dysplasia
|
2
|
1
|
0 |
0 |
0 |
3
|
|
Bardet-Biedl syndrome 12
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Biotin-responsive basal ganglia disease
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Cockayne spectrum with or without cerebrooculofacioskeletal syndrome
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome
|
0 |
2
|
0 |
0 |
0 |
2
|
|
Dyskeratosis congenita, autosomal recessive 5
|
2
|
0 |
0 |
0 |
0 |
2
|
|
GRACILE syndrome
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Hemochromatosis type 1
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Hurler syndrome
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Hyperinsulinemic hypoglycemia, familial, 2
|
1
|
1
|
0 |
0 |
0 |
2
|
|
Joubert syndrome 3
|
1
|
1
|
0 |
0 |
0 |
2
|
|
Maple syrup urine disease type 1B
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Maple syrup urine disease type 2
|
0 |
2
|
0 |
0 |
0 |
2
|
|
Myopathy, lactic acidosis, and sideroblastic anemia 1
|
0 |
2
|
0 |
0 |
0 |
2
|
|
Nephropathic cystinosis
|
1
|
1
|
0 |
0 |
0 |
2
|
|
Peroxisome biogenesis disorder 1A (Zellweger)
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Peroxisome biogenesis disorder 3A (Zellweger)
|
2
|
0 |
0 |
0 |
0 |
2
|
|
RAPSN-related disorder
|
1
|
1
|
0 |
0 |
0 |
2
|
|
Recombinase activating gene 2 deficiency
|
2
|
0 |
0 |
0 |
0 |
2
|
|
Spondylocostal dysostosis 2, autosomal recessive
|
1
|
1
|
0 |
0 |
0 |
2
|
|
Trimethylaminuria
|
0 |
2
|
0 |
0 |
0 |
2
|
|
VPS13A-related neurodegenerative disease
|
1
|
1
|
0 |
0 |
0 |
2
|
|
3-Methylglutaconic aciduria type 3
|
1
|
0 |
0 |
0 |
0 |
1
|
|
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency
|
0 |
1
|
0 |
0 |
0 |
1
|
|
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins
|
0 |
1
|
0 |
0 |
0 |
1
|
|
Ataxia-telangiectasia syndrome
|
0 |
0 |
1
|
0 |
0 |
1
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2I
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Congenital amegakaryocytic thrombocytopenia 1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
Donnai-Barrow syndrome
|
0 |
1
|
0 |
0 |
0 |
1
|
|
ENHANCED S-CONE SYNDROME 1
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Hereditary spastic paraplegia 49
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Hydrolethalus syndrome 1
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Intellectual disability, X-linked, with or without seizures, ARX-related
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Joubert syndrome 2
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Meckel syndrome, type 1
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Metaphyseal chondrodysplasia, McKusick type
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Microcephaly 1, primary, autosomal recessive
|
0 |
1
|
0 |
0 |
0 |
1
|
|
Microphthalmia, isolated, with coloboma 3
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Mitochondrial complex I deficiency, nuclear type 1
|
0 |
1
|
0 |
0 |
0 |
1
|
|
Multiple endocrine neoplasia type 2B
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Neurometabolic disorder due to serine deficiency
|
0 |
1
|
0 |
0 |
0 |
1
|
|
Neuronal ceroid lipofuscinosis 8
|
0 |
0 |
1
|
0 |
0 |
1
|
|
Peroxisome biogenesis disorder 1B
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Peroxisome biogenesis disorder 5A (Zellweger)
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Peroxisome biogenesis disorder type 3B
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Pontocerebellar hypoplasia type 1A
|
0 |
1
|
0 |
0 |
0 |
1
|
|
Primary ciliary dyskinesia 9
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Pseudo-Hurler polydystrophy
|
1
|
0 |
0 |
0 |
0 |
1
|
|
RPGR-related retinopathy
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Retinitis pigmentosa 59
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Salla disease
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Usher syndrome type 3
|
1
|
0 |
0 |
0 |
0 |
1
|
|
Usher syndrome type 3A
|
0 |
0 |
1
|
0 |
0 |
1
|
|
alpha Thalassemia
|
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. The submitted information has not been verified.
If you have questions about the information contained on this
website, please see a health care professional.